Telotristat clinical trials
Includes 22 studies of Telotristat ethyl.
How each study uses telotristat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 28 Feb 2017 · XERMELO · NDA 208794 (FDA, Drugs@FDA; as telotristat ethyl)
- European Union
- 17 Sept 2017 · Xermelo · EMEA/H/C/003937 (EMA; as telotristat ethyl)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
23 studies that test it; most in 2014 (7)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 7 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 16 · Other 7
Lexicon Pharmaceuticals (13) · Ipsen (2) · M.D. Anderson Cancer Center (1) · Emory University (1) · Barbara Ann Karmanos Cancer Institute (1) · Lowell Anthony, MD (1) · TerSera Therapeutics LLC (1) · Chandrikha Chandrasekhara (1)
Often tested with
Tested in the same studies.
Omeprazole (1) · Famotidine (1) · Octreotide (1) · Fexofenadine (1)
Studies
Open first, then newest update. How each study uses telotristat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 23
- Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine TumorActive, not recruitingPhase 3M.D. Anderson Cancer CenterNCT04810091Written as Telotristat EthylHow we know
- Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic CancerCompletedPhase 2Emory UniversityNCT03910387Written as Telotristat EthylHow we know
- AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine NeoplasmCompletedPhase 2Barbara Ann Karmanos Cancer InstituteNCT03453489Written as Telotristat EtiprateHow we know
- Telotristat With Lutathera in Neuroendocrine TumorsTerminatedPhase 2Lowell Anthony, MDNCT04543955Written as Telotristat (Low-Dose)How we know
- A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract CancerTerminatedPhase 2TerSera Therapeutics LLCNCT03790111Written as telotristat ethylHow we know
- Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat EthylWithdrawnPhase 2Chandrikha ChandrasekharaNCT04713202Written as Telotristat ethylHow we know
- Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine TumorsWithdrawnPhase 2University of ChicagoNCT04672876Written as Telotristat Ethyl Oral TabletHow we know
- Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal FunctionCompletedPhase 1IpsenNCT03442725Written as Telotristat etiprateHow we know
- Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid SyndromeWithdrawnPhase 3European Organisation for Research and Treatment of Cancer - EORTCNCT04065165Written as Telotristat EthylHow we know
- Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome SymptomsCompletedPhase 3Lexicon PharmaceuticalsNCT02026063Written as Telotristat etiprateHow we know
- A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative ColitisCompletedPhase 2Lexicon PharmaceuticalsNCT01456052Written as Telotristat EtiprateHow we know
- Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid SyndromeCompletedPhase 2Lexicon PharmaceuticalsNCT01104415Written as Telotristat etiprateHow we know
- Study to Evaluate a Dose of Telotristat Etiprate in Male and Female With Mild, Moderate and Severe Hepatic Insufficiency and Matched Healthy SubjectsCompletedPhase 1IpsenNCT02683577Written as telotristat etiprateHow we know
- Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide TherapyCompletedPhase 2Lexicon PharmaceuticalsNCT00853047Written as Telotristat etiprateHow we know
- Study to Evaluate the Pharmacokinetics of Telotristat Ethyl in Subjects With Severe Hepatic ImpairmentCompletedPhase 1Lexicon PharmaceuticalsNCT03423446Written as Telotristat EthylHow we know
- A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy SubjectsCompletedPhase 1Lexicon PharmaceuticalsNCT03302845Written as Telotristat ethyl 250 mgHow we know
- TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)CompletedPhase 3Lexicon PharmaceuticalsNCT01677910Written as Telotristat etiprateHow we know
- Telotristat Etiprate for Carcinoid Syndrome TherapyCompletedPhase 3Lexicon PharmaceuticalsNCT02063659Written as Telotristat etiprateHow we know
- Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy SubjectsCompletedPhase 1Lexicon PharmaceuticalsNCT02195635Written as Telotristat etiprateHow we know
- An Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Fexofenadine in Healthy SubjectsCompletedPhase 1Lexicon PharmaceuticalsNCT02157558Written as Telotristat etiprateHow we know
See all 23 studies that test telotristat →
Given beside what is tested · 1 — telotristat is usual care or a partner of the new treatment
Codes
What other systems call telotristat · ClinicalTrials.gg INT000100
- MeSH (NLM) C000592493telotristatOne source NLM
- UNII (FDA) 381V4FCV2ZTELOTRISTATConfirmed FDA, NLM, Wikidata
- RxNorm 1872382Confirmed FDA, Wikidata
- Wikidata Q27256725telotristatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152549TelotristatOne source FDA
- DrugBank DB14218One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000592493 | telotristat | One source NLM |
| UNII (FDA) | 381V4FCV2Z | TELOTRISTAT | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1872382 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27256725 | telotristat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152549 | Telotristat | One source FDA |
| DrugBank | DB14218 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.